Paper showing stroke risk reduction using FocusStart device published online in leading cardiology journal

Excerpt from our news release from today:  In a peer-reviewed paper published online on May 2 2018 by the Journal of the American College of Cardiology (JACC) last week, FocusStart personnel, aided by Mayo Clinic electrophysiologists, showed that by adding a small negative charge to the electrode tips of RF catheters, it is possible to prevent the formation of coagulum, and thus reduce the risk of thromboembolic events such as trans-ischemic attacks, or stroke. 

Atrial fibrillation is heart condition caused by erratic electrical signals, and can lead to stroke or death. RF ablation catheters are used to treat atrial fibrillation by disrupting the chaotic electrical signals, and allowing the heart to beat normally. However, the catheter procedure itself may increase the risk of stroke due to the coagulum which forms on the catheter tip. FocusStart’s technology is aimed at preventing particles from attaching to the catheter tip, and adding a margin of safety to RF ablation procedures.    

“It’s exciting to have our paper accepted into such a distinguished publication, such as JACC. It helps to validate the technology and the team’s hard work. Our next step is to complete the development of the device, submit documentation for regulatory approval, and get this product on the market in order to help save patient’s lives,” says James Kent, COO of FocusStart.  

Samuel Asirvatham, M.D., Mayo Clinic electrophysiologist and co-author of the study remarked: “We are pleased to see our work published in JACC. I look forward to seeing patients benefit from the technology that may increase the safety and efficacy of the atrial fibrillation procedures.”